J.M. Penninger
Amgen Research Institute and Ontario Cancer Institute
Princess Margaret Hospital
University Health Network
Department of Medical Biophysics
Canada
Name/email consistency: high
- CD45: new jobs for an old acquaintance. Penninger, J.M., Irie-Sasaki, J., Sasaki, T., Oliveira-dos-Santos, A.J. Nat. Immunol. (2001)
- Stem cells. PTEN--coupling tumor suppression to stem cells?. Penninger, J.M., Woodgett, J. Science (2001)
- Review of microbial infections and the immune response to cardiac antigens. Penninger, J.M., Bachmaier, K. J. Infect. Dis. (2000)
- The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation. Penninger, J.M., Fischer, K.D., Sasaki, T., Kozieradzki, I., Le, J., Tedford, K., Bachmaier, K., Ohashi, P.S., Bachmann, M.F. Eur. J. Immunol. (1999)
- The actin cytoskeleton and lymphocyte activation. Penninger, J.M., Crabtree, G.R. Cell (1999)
- Thymocyte selection in Vav and IRF-1 gene-deficient mice. Penninger, J.M., Mak, T.W. Immunol. Rev. (1998)
- The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Penninger, J.M., Sirard, C., Mittrücker, H.W., Chidgey, A., Kozieradzki, I., Nghiem, M., Hakem, A., Kimura, T., Timms, E., Boyd, R., Taniguchi, T., Matsuyama, T., Mak, T.W. Immunity (1997)